Ki Chang Keum
Papers
3
Total Citations
89
H-Index
3
About
Ki Chang Keum is a leading surgical oncologist whose research focuses on advancing transoral robotic surgery (TORS) for the treatment of advanced head and neck cancers. His major contributions lie in pioneering combined-modality approaches that integrate neoadjuvant chemotherapy with TORS, followed by customized adjuvant therapy, to improve outcomes for patients with stage III–IV oropharyngeal and laryngo-hypopharyngeal cancers. Keum’s landmark clinical trials, each cited over 25 times, have demonstrated the feasibility and safety of this strategy, offering a less morbid alternative to traditional chemoradiation while preserving organ function. His 2017 study on TORS-based therapy for advanced oropharyngeal squamous cell carcinoma (36 citations) established a new paradigm for managing T3–T4 tumors. Notably, Keum’s work has been instrumental in defining patient selection criteria and optimizing perioperative protocols, directly influencing clinical guidelines. Through these high-impact trials, he has reshaped the surgical landscape for head and neck oncology, providing evidence that robotic surgery can be effectively combined with systemic therapy to achieve favorable oncologic and functional outcomes in even the most challenging cases.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3